These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18504810)

  • 1. Amisulpride-induced dystonia.
    Das PP; Grover S; Sahoo M
    Aust N Z J Psychiatry; 2008 May; 42(5):430-1. PubMed ID: 18504810
    [No Abstract]   [Full Text] [Related]  

  • 2. Amisulpride-induced both oculogyric crisis and trismus.
    Mendhekar DN; Yajuvendra B; Aggarwal A
    Indian J Med Sci; 2008 Jun; 62(6):239-41. PubMed ID: 18603743
    [No Abstract]   [Full Text] [Related]  

  • 3. Pisa syndrome during amisulpride treatment.
    Li TC; Chiu HW; Liu HH
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352s.e27-352.e27. PubMed ID: 20686163
    [No Abstract]   [Full Text] [Related]  

  • 4. Tardive dystonia associated with low-dose of amisulpride: a case report.
    Sevincok L; Balci V; Akyildiz U
    J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
    [No Abstract]   [Full Text] [Related]  

  • 5. Amisulpride-induced tardive dystonia: a case report.
    Guriz O; Ekinci AE; Orsel S; Ekinci O
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):412-3. PubMed ID: 19944732
    [No Abstract]   [Full Text] [Related]  

  • 6. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive oculogyric crisis associated with amisulpride monotherapy.
    Mendhekar DN; Lohia D; Kataria P
    J Postgrad Med; 2010; 56(4):305-6. PubMed ID: 20935407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic bradycardia and hypotension associated with amisulpride: A case report.
    Su CH; Chen CS; Huang MF
    Asia Pac Psychiatry; 2016 Jun; 8(2):175. PubMed ID: 27062666
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin-induced acute dystonia in a schizophrenic patient treated with sulpiride and clozapine.
    Chen WH; Huang WL; Hsieh MH
    Psychiatry Clin Neurosci; 2016 Aug; 70(8):362-3. PubMed ID: 27193328
    [No Abstract]   [Full Text] [Related]  

  • 10. Amisulpride-induced mania in a patient with schizophrenia.
    Murphy BP
    Br J Psychiatry; 2003 Aug; 183():172. PubMed ID: 12893676
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amisulpride, and atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. The Amisulpride Study Group.
    Puech A; Fleurot O; Rein W
    Acta Psychiatr Scand; 1998 Jul; 98(1):65-72. PubMed ID: 9696517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol.
    Pogarell O; Juckel G; Mulert C; Amann B; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 Nov; 37(6):304-5. PubMed ID: 15551199
    [No Abstract]   [Full Text] [Related]  

  • 14. Amisulpride and cardiomyopathy.
    Brakoulias V; Bannan E; Cohen P; Geary G
    Aust N Z J Psychiatry; 2005 Aug; 39(8):738. PubMed ID: 16050932
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical advantages of amisulpride in the treatment of acute schizophrenia.
    Burns T; Bale R
    J Int Med Res; 2001; 29(6):451-66. PubMed ID: 11803729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The features of atypical neuroleptic amisulpride action].
    Grigor'eva EA; Ritskov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
    [No Abstract]   [Full Text] [Related]  

  • 17. Amisulpride-associated pedal edema.
    Chen CK; Chou YH
    Eur Psychiatry; 2004 Nov; 19(7):454-5. PubMed ID: 15504658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness and tolerability of amisulpride in patients with schizophrenia: results of a 6-month open study].
    Rzewuska M; Kuczyński W; Luks M
    Psychiatr Pol; 2004; 38(3):453-68. PubMed ID: 15199655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
    Lee SJ; Lee JH; Jung SW; Koo BH; Choi TY; Lee KH
    Clin Drug Investig; 2012 Nov; 32(11):735-45. PubMed ID: 23018281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].
    Pélissolo A; Krebs MO; Olié JP
    Encephale; 1996; 22(3):215-9. PubMed ID: 8767050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.